CellSeed, Inc.

CellSeed, Inc.

CellSeed, Inc.

Overview
Date Founded

2001

Headquarters

Telecom Center Building, 15/F,2-5-10 Aomi,Koto-Ku,Tokyo 135-0064

Type of Company

Public

Employees (Worldwide)

37

Industries

Pharmaceuticals
Biotechnology

Company Description

CellSeed Inc. develops regenerative medicine products. Its operations are carried out through the following business divisions: Cell Sheet Regenerative Medicine and Intelligent Cell Culture Ware Products. The Cell Sheet Regenerative Medicine division provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis. The Intelligent Cell Culture Ware Products division provides key cutting edge technology and solutions as well as tissue-engineered products such as corneas and skin. It also provides the basic technology services such as temperature responsive polymers and nano-bio interface. The company was founded by Yukio Hasegawa on May 9, 2001 and is headquartered in Tokyo, Japan.

Executives & Employees

Co-Founder

President, Chief Executive Officer & Representative Director

Executive Director

Executive Director

External Executive Director

Board of Directors

President & Chief Executive Officer at CellSeed, Inc.

Former Executive Director at CellSeed, Inc.

Director & Head-Tokai Hokuriku Block at Tokai University

Outside Director at CellSeed, Inc.

Paths to CellSeed, Inc.
Potential Connections via
Relationship Science
You
CellSeed, Inc.
Recent Transactions
Details Hidden

CellSeed, Inc. issued Ordinary Shares

Transaction Advisors
Underwriter

Advised onCellSeed, Inc. issued Ordinary Shares

Underwriter

Advised onCellSeed, Inc. issued Ordinary Shares

Underwriter

Advised onCellSeed, Inc. issued Ordinary Shares

Clients

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded in November 2006 and is headquartered in Waltham, MA.

Sigma Pharmaceuticals, LLC is a wholesale distributor of ophthalmic products to eye care practitioners across the United States. The company was founded in 1985 by Dr. Gary Fisher, President and CEO, and Marcia Fisher, CFO, whose goal was not only to provide a wide variety of name brand and generic pharmaceutical options, but also to meet the individual needs of practitioners. The knowledgeable and friendly staff at Sigma Pharmaceuticals makes every effort to provide one-on-one customer service, filling special requests for ophthalmic products not regularly carried. In 2007, Nichole Fisher joined the company as Director of Operations, ensuring that Sigma Pharmaceuticals remains committed to shipping only the highest quality ophthalmic products in a timely and cost-effective manner. Sigma Pharmaceuticals does not have a minimum order requirement and is proud of the fact that the company’s rates have remained competitive within the industry

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2017
Market Capitalization
$7.46B
Total Enterprise Value
$3.44B
Earnings Per Share
$-93.3
Revenue
$85.1M
EBITDAMargin
-1,199.19%
Total Equity
$1.26B
Net Profit
$-966M
EBITDA
$-1.02B
Enterprise Value Sales
40.39x
TEVNet Income
-3.55x
Debt TEV
0x
Total Debt
$0
Three Year Compounded Annual Growth Rate Of Revenue
-0.49%
Five Year Compounded Annual Growth Rate Of Revenue
2.51%
Suppliers
Dai Nippon Printing Co Ltd. Printing | Tokyo, TY

Dai Nippon Printing Co., Ltd. engages in the provision of publishing and commercial printing services. It operates through the following segments: Information Communication, Lifestyle and Industrial Supplies, Electronics, and Beverages. The Information Communication segment involves in the manufacture and sale of publications, commercial printing materials, business forms, and educational and publications distribution. The Lifestyle and Industrial Supplies segment offers packaging materials, interior and exterior construction materials, photographic materials, and industrial supplies. The Electronics segment handles precision electronic components and other products. The Beverages segment produces and sells carbonated and non-carbonated beverages. The company was founded on October 9, 1876 and is headquartered in Tokyo, Japan.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CellSeed, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CellSeed, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CellSeed, Inc..